Česky
A new oncology pavilion is due to open this autumn. It is a project that raises great expectations. What do you expect from it?
The outpatient clinics of the Comprehensive Oncology Centre, which are currently located in several buildings on the hospital premises, will be relocated to the new oncology pavilion. The new modern building will bring high comfort for both patients and staff. I am very happy that especially patients undergoing therapy at the inpatient unit will, after many years, receive decent conditions for the application of anti-cancer systemic treatment.
What are your plans for this year and the coming year?
In the next year, the addition of software for the preparation and planning of radiation treatment is planned. The benefits will be both to improve the quality of the treatment performed and to speed up its preparation, thus reducing the waiting time for the start of therapy. It will be essential for us to replace the linear accelerator with a more modern one, and above all compatible with the existing device. This will increase the availability of modern methods of radiotherapy and simplify operations in the event of a failure of one of these machines.
In a couple of weeks, the traditional Controversies in Oncology conference will take place, bringing together oncologists from all over the country. Can you briefly describe what the participants can look forward to?
On 16-17 May 2019, the 9th edition of this professional conference will take place, which has already become one of the traditional professional events for cancer physicians. It is a conference held under the auspices of the Society of Radiation Oncology, Biology and Physics and guaranteed by the Czech Society of Oncology of the Czech Cancer Society. Traditionally, the professional programme is attended by top lecturers, representatives of renowned oncology departments from the Czech Republic and colleagues from our department. A special event of this year's event will be the awarding of the Gold Commemorative Medal of the ČLS JEP to Prof. Michael Brad, a leading expert in the field of neuro-oncology, currently based at the University of Liverpool. We can look forward to a lecture entitled "Radiosurgery and radiotherapy for brain metastases; it's all about endpoints."
You have been elected a member of the review committee of the Czech Medical Society of Jan Evangelista Purkyně. What does this mean for you?
I consider it a great honour to have been elected to this position, and I expect that I will use my experience from my work as the chair of the revision committee of the Czech Society of Clinical Trials of the European Academy of Pediatrics and as a member of the revision committee of the ČLK Pardubice.
